Navigation Links
Drug Might Restore Sense of Smell
Date:7/10/2009

Study found more than half of patients reported improvement

FRIDAY, July 10 (HealthDay News) -- A drug once used to treat asthma and other respiratory conditions shows promise in restoring a sense of smell to those who have lost that precious ability.

"More work needs to be done but, for patients for whom other treatments don't work, this may be an option worth trying," said Dr. Ronald Kuppersmith, clinical assistant professor of surgery at Texas A&M Health Science Center College of Medicine and president-elect of the American Academy of Otolaryngology-Head and Neck Surgery.

The drug, theophylline, does have side effects and is now out of vogue for asthma and related disorders, said Kuppersmith, who was not involved in the study.

According to background information in the article, about 20 million people in the United States have some degree of hyposmia, or loss of the sense of smell, affecting their ability to enjoy the flavor of artichokes and the fragrance of azaleas.

"There's a whole spectrum from having mild changes in your sense of smell to complete loss," Kuppersmith said. "It can be very frustrating for the patient, but also for the physician. A lot of people can't enjoy coffee because they can't smell it. They lose weight. They can't smell flowers."

Any number of things can cause the problem. "The most common causes are viruses, head trauma, severe allergies or some kind of anatomic obstruction in the nose or nasal polyps," Kuppersmith explained.

In June, U.S. health officials warned consumers to stop using Zicam nasal cold remedy products because they can cause the loss of a sense of smell.

According to Dr. Robert Henkin, lead author of the study that appears in the June issue of the American Journal of the Medical Sciences, there are few effective treatments out there.

Henkin, director of the Center for Molecular Nutrition and Sensory Disorders in Washington, D.C., and his colleagues had previously discovered that people with hyposmia had reduced levels of cyclic nucleotides in their saliva and nasal mucous, and that treatment with theophylline had increased levels of this growth factor and restored some of the sense of smell.

These cyclic nucleotides are growth factors for olfactory (related to smell) and other neural tissues.

"I had earlier done the first total protein analysis of saliva and mucous to learn what was in there, and found these growth factors and found that people who couldn't smell had diminished levels of the factors," Henkin explained. "Theophylline, in a sense, inhibits the breakdown of growth factors so more are going to stick around."

Henkin and his team have now confirmed the efficacy of theophylline in this context in 312 patients with hyposmia over a seven-year study period.

All of the study participants had decreased levels of growth factors cAMP and/or cGMP, as measured in their nasal mucous.

More than half of participants said their sense of smell improved after being treated with theophylline, while more than 20 percent said their smell returned to normal. Larger doses of the compound and longer treatment times resulted in greater improvements.

"People who had relatively mild or moderate disease seemed to respond to this treatment but those patients tend to respond to other treatments as well," Kuppersmith said. "Most of those who had severe or complete loss of sense of smell didn't respond, which is typical of a lot of treatments out there."

Also, he said, "some people who lose their sense of smell get better anyway, especially if they have mild cases, so they would have gotten better with or without treatment."

But, Kuppersmith added, for certain patients this might be a helpful option if other things don't work.

Side effects of theophylline were minimal, the researchers noted, but can include jitteriness, nervousness and difficulty falling asleep.

Henkin said that the findings need to be verified with a clinical trial. His team is now looking at ways to deliver the drug intranasally (this study involved pills). He also needs a drug company to develop and market the medication, should it continue to prove useful.

More information

The Sense of Smell Institute has more on hyposmia.



SOURCES: Robert I. Henkin, M.D., Ph.D., director, Center for Molecular Nutrition and Sensory Disorders, Washington, D.C.; Ronald Kuppersmith, M.D., clinical assistant professor, surgery, Texas A&M Health Science Center College of Medicine, otolaryngologist, Texas ENT and Allergy, College Station, and president-elect, American Academy of Otolaryngology-Head and Neck Surgery; June 2009, American Journal of the Medical Sciences


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fish Oil Might Help Relieve MS
2. HIV Drug Might Fight Cancer
3. High and mighty: first common height gene identified by researchers behind obesity gene finding
4. Vitamin C Plus Fat Might Spur Cancer
5. Mathematics might save you a trip to the ER
6. Veggies Might Ward Off Age-Linked Vision Woes
7. Rating your pain from 0 to 10 might not help your doctor
8. Blood Marker Might Help Spot Early Liver Cancer
9. Hushed Genes Might Mean Higher Lung Cancer Risk
10. Mathematics might save you a trip to the ER
11. More Prostate Cancers Might Be Prevented
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Might Restore Sense of Smell
(Date:4/29/2016)... ... April 29, 2016 , ... ... flexibility in repaying their loans, more information about their loan terms and accounts, ... outstanding student loan debt, including federal and private loans, has reached $1.3 trillion, ...
(Date:4/29/2016)... ... April 29, 2016 , ... A ... born with severe congenital diaphragmatic hernia have better survival rates if surgery is ... hernia (CDH)—a condition where the diaphragm fails to form completely, letting abdominal organs ...
(Date:4/29/2016)... Kansas City, Missouri (PRWEB) , ... April 29, 2016 , ... ... Unlike traditional crutches which put pressure on the armpits, the M+D Crutch evenly distributes ... less strain on their wrists and hands when using the crutches than with other ...
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  The blood testing market ... dollars, according to Kalorama Information and The Freedonia Group ... and nucleic acid testing.  The healthcare research firm said ... in developing blood collection stations and in improving testing ... Kalorama Information,s report, Blood Testing Market in ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life ... Pharmacovigilance team to bring a wealth of insight to a growing ... pharmacovigilance knowledge. George Phillips joined ArisGlobal in ...
(Date:4/28/2016)... 28, 2016  ValGenesis, Inc., the market ... (VLMS) today announced that a prominent world ... of chronic kidney failure has selected ValGenesis ... corporate validation process. The global medical device ... to manage their validation processes electronically. Upon ...
Breaking Medicine Technology: